T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.37% |
| 2 | Financials | 13.66% |
| 3 | Consumer Discretionary | 13.64% |
| 4 | Technology | 10.86% |
| 5 | Industrials | 10.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IVAC
1126
DELISTED
Intevac Inc
IVAC
| $20.3M | ﹤0.01% |
3,478,216
-1,800
| -0.1% | -$9.88K |
|
1127
Equity Lifestyle Properties
ELS
$12.7B
| $20.3M | ﹤0.01% |
773,880
+41,200
| +6% | +$1.11M |
|
1128
Qorvo
QRVO
$8.56B
| $20.3M | ﹤0.01% |
253,310
+207,839
| +457% | +$16.1M |
|
|
LDL
1129
DELISTED
Lydall, Inc.
LDL
| $20.3M | ﹤0.01% |
687,210
+120
| +0% | +$3.47K |
|
|
THR
1130
DELISTED
Thermon Group Holdings
THR
| $20.2M | ﹤0.01% |
840,470
-900
| -0.1% | -$21.1K |
|
1131
Broadridge
BR
$19.4B
| $20.1M | ﹤0.01% |
402,125
+367,900
| +1,075% | +$19.6M |
|
|
WGL
1132
DELISTED
Wgl Holdings
WGL
| $20.1M | ﹤0.01% |
369,438
+313
| +0.1% | +$17.5K |
|
|
KALV
1133
DELISTED
KalVista Pharmaceuticals
KALV
| $20M | ﹤0.01% |
+200,236
| New | +$19.9M |
|
1134
Graphic Packaging
GPK
$3.39B
| $20M | ﹤0.01% |
1,435,613
-1,400
| -0.1% | -$20.1K |
|
1135
Molson Coors Class B
TAP
$7.91B
| $20M | ﹤0.01% |
286,038
+20,500
| +8% | +$1.52M |
|
|
PNY
1136
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
| $20M | ﹤0.01% |
565,090
+150
| +0% | +$5.53K |
|
|
PHX
1137
DELISTED
PHX Minerals
PHX
| $19.7M | ﹤0.01% |
952,970
+8,100
| +0.9% | +$173K |
|
|
TMX
1138
DELISTED
Terminix Global Holdings, Inc.
TMX
| $19.7M | ﹤0.01% |
813,386
+338,164
| +71% | +$7.85M |
|
1139
Euronet Worldwide
EEFT
$2.72B
| $19.6M | ﹤0.01% |
318,250
+3,600
| +1% | +$214K |
|
1140
Republic Services
RSG
$66.1B
| $19.6M | ﹤0.01% |
499,885
-84,175
| -14% | -$3.39M |
|
1141
Golub Capital BDC
GBDC
$3.45B
| $19.6M | ﹤0.01% |
1,206,608
-3,583
| -0.3% | -$60.7K |
|
|
ZEN
1142
DELISTED
ZENDESK INC
ZEN
| $19.5M | ﹤0.01% |
879,852
+591,016
| +205% | +$13.6M |
|
|
CIVI
1143
DELISTED
Civitas Resources
CIVI
| $19.4M | ﹤0.01% |
9,512
-641
| -6% | -$1.66M |
|
|
SEE
1144
DELISTED
Sealed Air
SEE
| $19.3M | ﹤0.01% |
374,801
+3,070
| +0.8% | +$148K |
|
|
DST
1145
DELISTED
DST Systems Inc.
DST
| $19.2M | ﹤0.01% |
305,526
+42,400
| +16% | +$2.51M |
|
|
SEMG
1146
DELISTED
SEMGROUP CORPORATION
SEMG
| $19.2M | ﹤0.01% |
241,800
-3,200
| -1% | -$261K |
|
|
GIFI
1147
DELISTED
Gulf Island Fabrication
GIFI
| $19.1M | ﹤0.01% |
1,709,475
+3,900
| +0.2% | +$49.7K |
|
1148
Utah Medical Products
UTMD
$230M
| $19M | ﹤0.01% |
318,840
+450
| +0.1% | +$25.3K |
|
1149
Oil-Dri
ODC
$1.3B
| $19M | ﹤0.01% |
1,248,280
-750
| -0.1% | -$11.9K |
|
|
CADE
1150
DELISTED
Cadence Bank
CADE
| $18.9M | ﹤0.01% |
735,585
-46,000
| -6% | -$1.14M |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.